agilon health, inc. (NYSE:AGL) Forecasted to Earn Q3 2024 Earnings of ($0.08) Per Share

agilon health, inc. (NYSE:AGL) – Equities research analysts at William Blair raised their Q3 2024 EPS estimates for agilon health in a research note issued on Tuesday, August 6th. William Blair analyst R. Daniels now anticipates that the company will post earnings of ($0.08) per share for the quarter, up from their previous forecast of ($0.10). The consensus estimate for agilon health’s current full-year earnings is ($0.34) per share. William Blair also issued estimates for agilon health’s Q4 2024 earnings at ($0.14) EPS, Q3 2025 earnings at ($0.05) EPS, Q4 2025 earnings at ($0.10) EPS and FY2025 earnings at ($0.11) EPS.

AGL has been the topic of several other reports. Deutsche Bank Aktiengesellschaft reduced their price objective on shares of agilon health from $5.00 to $4.00 and set a “hold” rating on the stock in a report on Friday. Robert W. Baird began coverage on agilon health in a research report on Thursday, May 30th. They issued a “neutral” rating and a $6.00 price target for the company. Stifel Nicolaus reduced their price objective on agilon health from $8.00 to $7.00 and set a “hold” rating on the stock in a research note on Wednesday, May 1st. Baird R W upgraded agilon health to a “hold” rating in a research report on Thursday, May 30th. Finally, Citigroup started coverage on agilon health in a research report on Monday, April 22nd. They set a “neutral” rating and a $6.00 target price on the stock. One analyst has rated the stock with a sell rating, fourteen have assigned a hold rating and four have issued a buy rating to the stock. According to MarketBeat, agilon health currently has a consensus rating of “Hold” and an average price target of $8.57.

agilon health Trading Down 1.4 %

Shares of AGL opened at $5.52 on Friday. agilon health has a 52-week low of $4.41 and a 52-week high of $20.37. The company has a quick ratio of 1.33, a current ratio of 1.33 and a debt-to-equity ratio of 0.04. The firm’s fifty day moving average is $6.51 and its two-hundred day moving average is $5.99. The stock has a market cap of $2.27 billion, a PE ratio of -7.89 and a beta of 0.60.

agilon health (NYSE:AGL) last posted its quarterly earnings results on Tuesday, August 6th. The company reported ($0.07) EPS for the quarter, hitting the consensus estimate of ($0.07). The company had revenue of $1.48 billion for the quarter, compared to the consensus estimate of $1.56 billion. agilon health had a negative net margin of 5.67% and a negative return on equity of 26.15%. The firm’s revenue was up 38.7% compared to the same quarter last year. During the same quarter last year, the firm posted ($0.04) EPS.

Institutional Trading of agilon health

A number of hedge funds and other institutional investors have recently modified their holdings of the company. Capital World Investors increased its holdings in shares of agilon health by 7.4% in the 4th quarter. Capital World Investors now owns 55,218,496 shares of the company’s stock worth $692,992,000 after buying an additional 3,813,214 shares during the last quarter. Wellington Management Group LLP lifted its position in shares of agilon health by 2.9% in the 4th quarter. Wellington Management Group LLP now owns 42,510,030 shares of the company’s stock worth $533,501,000 after purchasing an additional 1,191,253 shares during the period. Vanguard Group Inc. raised its stake in shares of agilon health by 1.3% during the 1st quarter. Vanguard Group Inc. now owns 28,947,798 shares of the company’s stock worth $176,582,000 after acquiring an additional 371,537 shares in the last quarter. Capital International Investors raised its stake in shares of agilon health by 84.7% during the 1st quarter. Capital International Investors now owns 20,197,932 shares of the company’s stock worth $123,207,000 after acquiring an additional 9,263,296 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD increased its stake in agilon health by 46.0% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 10,139,886 shares of the company’s stock valued at $127,256,000 after purchasing an additional 3,195,087 shares in the last quarter.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.